Joyspan: The Secret to Retention in Longevity
How ROI changes when you design for joy on purpose, not by accident.
Joyspan is the cheapest longevity lever I know.
It costs nothing. You can start today.
No labs. No drips. No devices.
Just a decision to feel more joy in the life you already have.
The other day I came across a Joyspan experiment in San Francisco: a “longevity rave” where participants went substance-free, logged their mood, then danced wired up to wearables while researchers took blood and saliva before and after. They were looking at brain waves, heart rhythms and biomarkers related to inflammation and mitochondrial stress, trying to compress all of that into a “JoyScore” – a data trace of joy and connection in the body.
It sounds like peak Silicon Valley, but the underlying instinct is right: joy is not just a feeling. It has a biological footprint.
Over the last few years, several groups have shown that daily mood and psychosocial experiences are linked to mitochondrial health markers. Higher positive mood has been associated with a higher “mitochondrial health index” in blood cells, and some of the impact of chronic stress on mitochondria appears to be mediated by lower daily positive affect. Newer work suggests that people with more positive psychosocial experiences show greater abundance and efficiency of mitochondrial energy machinery, whereas chronic psychological stress and distress are tied to mitochondrial dysfunction and higher disease risk.
All of this is still relatively early and largely associational. No one can honestly say “increase joy by X and your mitochondria improve by Y.” If every mitochondrial paper vanished tomorrow, the business case for joyspan would still stand on behaviour, connection and retention. But taken together, the data make one thing clear: chronic stress and negative affect damage the energy system; better mood and wellbeing are associated with more robust mitochondrial profiles. Joy is not only “in your head”. It shows up in how your cells handle energy.
If you’re building a longevity business, that matters. Your clients’ mitochondria are where lifespan, healthspan and joyspan all meet.
From that angle, joyspan isn’t a soft idea. It’s one of the most financially rational things you can build into a health business.
Since becoming a parent, this stopped being abstract. There are only so many mornings, school runs, bedtimes. My son won’t copy what I say about health; he’ll absorb the emotional baseline I live in. At the same time, I’m a founder, building a medically led clinic and diagnostics capability in Portugal. Most of my day is protocols, equipment, regulation, unit economics.
Joyspan sits at the junction of those two roles. It is both a personal operating principle and, in my view, a hard commercial lever.
Joyspan, in operator language
We already design for two spans:
Lifespan – how long you are alive.
Healthspan – how long you can function as you wish.
There’s a third span almost no one designs around:
Joyspan – the share of your functional years that actually feel worth being alive for.
Think of joyspan as the proportion of “healthy” years where you have real reasons to get out of bed - laughter, meaning, people you’re glad to see - instead of just more time to manage admin and anxiety.
We have enough evidence to treat this as more than poetry:
higher subjective well-being is associated with lower mortality and fewer cardiovascular events
stronger social connection is associated with longer life and better health
loneliness and isolation carry a substantially elevated risk of premature death, on a par with major lifestyle risks
On top of that, early human work shows that daily mood and psychosocial experiences are associated with mitochondrial health and cellular bioenergetics.
Most of this is associative, not perfectly causal. That’s fine. If you’re designing a business, it’s irrational to ignore a factor that:
tracks with hard outcomes
shapes daily behaviour
influences the cellular machinery you claim to care about
heavily affects whether people stay in your product or quietly leave
Joyspan doesn’t replace the hard risk-factor work (sleep, blood pressure, metabolic health, depression treatment). It multiplies the odds that people will actually do that work and keep doing it. If risk-factor work is your principal, joyspan is the interest rate on adherence.
Why joyspan beats “one more biomarker”
Joyspan shows up in three places that directly affect your P&L: behaviour, biology and experience.
1. Behaviour → adherence → outcomes
Clients who feel better and more connected are more likely to:
move regularly
avoid heavy smoking and drinking
stick to treatment plans
show up to appointments
Over years, that behaviour change drives most of the benefit any clinic can claim. If someone is chronically joy-poor, all the “healthy routines” you prescribe sit on brittle ground. They comply in bursts, then drop off. That turns into:
disappointing long-term outcomes
flat NPS
weak renewal curves
2. Biology → amplifying what you already do
Chronic emotional states show up in:
stress hormones
inflammatory markers
heart-rate variability
sleep architecture
and, increasingly, mitochondrial structure and function
A system running on constant rush and low-grade fear stays in threat mode and builds “mitochondrial allostatic load” – wear and tear on the energy system. A system that regularly experiences safety, connection and gratitude spends more time in repair and in efficient energy production.
You do not need a perfect causal model to see that this interacts with every drug, protocol and device you sell.
3. Experience → retention and LTV
Clients do not experience your product as “protocol + labs + app”. They experience their week:
waking up
going to work
parenting
going to sleep
If their numbers improve but their week feels emotionally unchanged - or more stressful because of added tasks and fear - they leave when a cheaper or more convenient option appears.
If their week feels noticeably better after engaging with you - calmer, more energised, more connected - they think twice before cancelling. That is the commercial core of joyspan: it multiplies adherence, amplifies biological effects and turns your offer into something people don’t want to lose.
What I learnt in places I’d never build
I’ve done my share of retreats—the kind serious people roll their eyes at. I wouldn’t build a company in that container. But I did pick up something useful: how to notice what I actually feel, how to self-regulate instead of outsourcing that job, how to sit with difficult emotions without instantly numbing, and how to feel genuine gratitude for being alive.
Those skills have shifted my day-to-day more than any device, drip or lab panel.
The content—emotional regulation, presence, gratitude—is not the problem. The packaging is. Most of your clients do not want their emotional operating system from a pseudo-spiritual circus.
That’s the opportunity:
take the parts that work
strip out the theatre
deliver them in a clinical, grounded, repeatable way
And do it in group formats that are:
cheap to deliver
easy to standardise and improve
clearly felt as valuable by clients
Operationally and financially, that’s attractive. Anyone can bolt a wellness ritual onto a lab. Designing around joyspan means you reroute intake, plans and follow-up so that a flat joy curve is treated like any other red flag.
Saturdays sell, Tuesdays retain
Back to San Francisco.
In the JoyScore experiment, a small group went clean for several days (no substances, no alcohol, limited caffeine), logged mood and energy, then spent a structured night in a Market Street tower: finger-prick blood draws for stress and inflammation markers, saliva for cortisol and oxytocin, an ear-clip EEG, then three hours of carefully engineered techno tracks while researchers watched their physiology dance.
It was more science experiment than the rave of anyone’s life. But the aim was clear: can you see joy and connection in the data, including biomarkers linked to mitochondrial stress and recovery?
Most of the wellness market optimises peaks like that: retreats, drips, spectacular moments. They’re easy to market and photograph. A drip bar can sell you a Saturday high.
But retention is decided by Tuesdays:
Did my normal week feel better?
Am I less frazzled?
Do I have more real moments of joy?
If your service doesn’t move how Tuesdays feel, your peaks won’t save you from churn. A serious longevity clinic has to make Tuesday mornings better. Only that builds LTV. Joyspan is Tuesday infrastructure.
Joyspan as an operating constraint
You can compress a lot of the mechanism into four rules:
Presence kills rushing.
Possibility kills fear.
Gratitude kills stress.
Signal kills noise.
These are more than nice lines. They’re design constraints.
If your clinic or programme systematically creates:
rush (too many touchpoints, too much friction)
fear (overwhelming risk framing, scary dashboards)
stress (complex routines, constant alerts)
noise (too many metrics, no clear priorities)
…you are burning joyspan. Burned joyspan shows up later as churn and low referrals.
We now have early evidence that the stories in your head—your ongoing stress, your sense of safety, your daily mood—are associated with how your mitochondria behave and how your energy system copes with load. Thought patterns and emotional states change how you spend and replenish energy, day by day.
From a business perspective, joy behaves like a broad-spectrum, upstream intervention:
it changes daily decisions
shifts stress physiology and inflammation
improves sleep and social connection
I call it a “multi-target drug” metaphorically: not because it’s a regulated product, but because its footprint across systems is broader than most single interventions. Ignoring that is like ignoring sleep.
Where joyspan lives in a health business
Joyspan belongs at the bottom of the stack next to sleep and stress, not at the top as a spa extra.
Practically, that means building it into three layers:
1. Assessment
You don’t stop at labs and step count. You add something as simple as:
“In the last 7 days, how many separate moments felt genuinely joyful?”
“What were two of them?”
You track that trend. If joyspan is consistently near zero, you treat it as a core risk signal - alongside blood pressure or HbA1c - not a side note.
Internally, you assume:
“If joyspan hasn’t moved in the first 8–12 weeks, long-term retention is at risk.”
That makes joyspan a product KPI, not a decoration. A flat joyspan curve is handled like any other worrying trend: it triggers action.
2. Programme design
Every plan has two parts:
the risk-factor work (sleep, metabolic, musculoskeletal, mental health)
at least one recurring element the client genuinely looks forward to
In reviews, you talk about LDL and blood pressure and you ask:
“Did you have more, fewer or the same number of joyful moments last week?”
“What changed when that number moved?”
If everything you prescribe feels like work, adherence quietly dies. When adherence dies, outcomes and renewals follow.
3. Follow-up and escalation
If biomarkers improve but:
joyspan is flat or falling
the client is more anxious or isolated
the routines feel like a burden
…you treat that as a failed intervention. You simplify, adjust, or—where appropriate—refer into formal mental health care. You don’t call that success just because the lab is green.
Alongside this, you bake in group-based emotional skills and connection sessions:
clearly positioned within EU and Portuguese regulatory boundaries (wellbeing / coaching vs medical where appropriate)
designed or overseen with clinical input
measured against changes in perceived stress, joyspan and engagement
They’re low marginal cost, emotionally high-impact, and tightly linked to “how my life feels”, which is what clients actually pay to change.
The financial logic
From an investor or operator lens, joyspan is financially sane because it improves three things:
1. Retention
People keep paying for things that:
clearly improve how their life feels
fit into their routines
feel emotionally safe and supportive
If your product moves joyspan in the right direction within weeks, people are far more likely to:
stay in your membership
accept price increases
move up tiers when it makes sense
If it doesn’t, they will rationalise churn: “too busy”, “too expensive”, “I’ll pause for now.”
We plan to test the hypothesis that clients whose joyspan improves in the first quarter have meaningfully better 12-month retention and referral than those whose joyspan is flat. If that proves true, joyspan becomes not just a philosophy but a management tool.
2. Referral
Most genuine word-of-mouth distils to:
“I just feel better on this.”
You can’t fake that with branding. You earn it with a persistent shift in how someone’s week feels. Joyspan is the closest thing to that reality you can track.
Higher joyspan → higher odds they talk about you at dinner, in founder groups, in WhatsApp chats. That lowers effective CAC over time.
3. Return on complexity
Every new device, protocol or feature adds operational complexity. The only good reason to add complexity is if it clearly improves:
outcomes, or
the emotional experience of being your client
Joyspan-focused features do both:
better emotional state → better behaviour → better outcomes
better emotional state → more enjoyable engagement with your product
That’s a much cleaner justification than “this looks cool in the brochure”.
A quick operator tool: the three-span ledger
One slide, three rows:
Lifespan – years alive
Healthspan – years functional
Joyspan – years that feel worth being alive
Columns:
“What our product is doing for this now”
“What we will change in the next 12 months”
Fill it in honestly.
Most health businesses have plenty to say under lifespan and healthspan—tests, scans, programmes—and almost nothing concrete under joyspan.
That blank row is not just an ethical gap. It’s a commercial risk. It’s where churn hides and where LTV flattens.
For me, this isn’t abstract. It’s anchored in two realities: a son who watches how I live every day, and a clinic and lab I’m quietly building in Portugal.
If I extend someone’s lifespan and healthspan but their joyspan stays flat, I’ve given them a longer corridor, not a better life. If I build a business that optimises biomarkers but leaves people emotionally unchanged, I’ve built something fragile and expensive.
Adding joyspan to a health business is not softness. It’s discipline:
it improves adherence and outcomes
it strengthens retention and referral
it makes complexity earn its keep
Joyspan is not a bonus. It’s the yield you are actually alive - and actually in business - to collect.
This is an educational and strategic perspective, not personal medical advice.




Love this perspective and piece 💪🏻❤️
This is a deceptively “soft” post that’s actually very hard-nosed systems thinking. As a physician-scientist, I love the core reframing: joyspan is an adherence multiplier. If sleep, metabolic control, strength training, and mental health care are the “principal”, then the felt quality of someone’s week is the interest rate that determines whether they keep paying into that principal long enough to see compounding benefits. That’s true behaviorally (habits stick when life feels worth engaging with) and plausibly biologically (affect and chronic stress states show up in autonomic tone, inflammation, and mitochondrial function). On the operator side, the retention/LTV/moat point is the sharpest: most longevity products compete on protocols and data, but people don’t churn because your biomarkers are slightly worse; they churn because their Tuesdays don’t feel meaningfully better. Designing for “felt improvement” (connection, competence, agency, belonging) isn’t branding; it’s product architecture. Also appreciate the honesty that the biomarker story is early/associational; you’re not overselling a JoyScore. But you are correctly arguing that even if the mitochondrial literature vanished tomorrow, the business case would stand, because joyspan is what keeps people in the behaviors that do move risk.